Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?

Abstract Background/Objective Delays in times to surgery, chemotherapy, and radiotherapy impair survival in breast cancer patients. Neoadjuvant chemotherapy (NAC) confers equivalent survival to adjuvant chemotherapy (AC), but it remains unknown which approach facilitates faster initiation and comple...

Full description

Bibliographic Details
Main Authors: Nicole M. Melchior, Darren B. Sachs, Gabrielle Gauvin, Cecilia Chang, Chihsiung E. Wang, Elin R. Sigurdson, John M. Daly, Allison A. Aggon, Shelly B. Hayes, Elias I. Obeid, Richard J. Bleicher
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:Cancer Medicine
Subjects:
breast cancer
cancer management
neoadjuvant chemotherapy
surgery
Online Access:https://doi.org/10.1002/cam4.2912

Internet

https://doi.org/10.1002/cam4.2912

Similar Items